Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
Submitted Feb 08 2011 10:22 AM
Nonmelanoma skin cancer is one of the most common malignancies in humans. Different therapeutic strategies for the treatment of these tumors are currently being investigated. Given thegrowth-inhibiting effects of cannabinoids on gliomas and the wide tissue distribution of the two subtypes of cannabinoid receptors (CB1and CB2), we studied the potential utility of these compounds in anti–skin tumor therapy.